Rohto Pharmaceutical RPHCF Stock
Rohto Pharmaceutical Price Chart
Rohto Pharmaceutical RPHCF Financial and Trading Overview
| Rohto Pharmaceutical stock price | 17.2 USD |
| Previous Close | 17.2 USD |
| Open | 15.2 USD |
| Bid | 16.9 USD x 50000 |
| Ask | 18.5 USD x 50000 |
| Day's Range | 15.2 - 15.2 USD |
| 52 Week Range | 14.34 - 17.2 USD |
| Volume | 150 USD |
| Avg. Volume | 2 USD |
| Market Cap | 3.88B USD |
| Beta (5Y Monthly) | -0.407 |
| PE Ratio (TTM) | 18.896593 |
| EPS (TTM) | 0.91 USD |
| Forward Dividend & Yield | 0.32 (1.83%) |
| Ex-Dividend Date | March 30, 2027 |
| 1y Target Est | N/A |
RPHCF Valuation Measures
| Enterprise Value | -3814341120 USD |
| Trailing P/E | 18.896593 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.01096959 |
| Price/Book (mrq) | 1.9878473 |
| Enterprise Value/Revenue | -0.011 |
| Enterprise Value/EBITDA | -0.062 |
Trading Information
Rohto Pharmaceutical Stock Price History
| Beta (5Y Monthly) | -0.407 |
| 52-Week Change | 16.81% |
| S&P500 52-Week Change | 12.83% |
| 52 Week High | 17.2 USD |
| 52 Week Low | 14.34 USD |
| 50-Day Moving Average | 15.61 USD |
| 200-Day Moving Average | 15.41 USD |
RPHCF Share Statistics
| Avg. Volume (3 month) | 2 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 225.43M |
| Float | 200.75M |
| Short Ratio | N/A |
| % Held by Insiders | 10.97% |
| % Held by Institutions | 38.48% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 46 |
| Trailing Annual Dividend Yield | 267.50% |
| 5 Year Average Dividend Yield | 98.00% |
| Payout Ratio | 0.49150002 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 9.37% |
| Operating Margin (ttm) | 14.81% |
| Gross Margin | 56.15% |
| EBITDA Margin | 17.28% |
Management Effectiveness
| Return on Assets (ttm) | 5.82% |
| Return on Equity (ttm) | 10.90% |
Income Statement
| Revenue (ttm) | 353.38B USD |
| Revenue Per Share (ttm) | 1563.9 USD |
| Quarterly Revenue Growth (yoy) | 11.79% |
| Gross Profit (ttm) | 198.44B USD |
| EBITDA | 61.09B USD |
| Net Income Avi to Common (ttm) | 33.13B USD |
| Diluted EPS (ttm) | 0.91 |
| Quarterly Earnings Growth (yoy) | -9.50% |
Balance Sheet
| Total Cash (mrq) | 84.77B USD |
| Total Cash Per Share (mrq) | 375.15 USD |
| Total Debt (mrq) | 58.1B USD |
| Total Debt/Equity (mrq) | 17.69 USD |
| Current Ratio (mrq) | 2.168 |
| Book Value Per Share (mrq) | 8.650514 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Rohto Pharmaceutical
| Country | United States |
| State | N/A |
| City | Osaka |
| Address | 1-8-1 Tatsuminishi |
| ZIP | 544-8666 |
| Phone | 81 6 6758 1231 |
| Website | https://www.rohto.co.jp |
| Industry | Household & Personal Products |
| Sector(s) | Consumer Defensive |
| Full Time Employees | 9292 |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.
Q&A For Rohto Pharmaceutical Stock
What is a current RPHCF stock price?
Rohto Pharmaceutical RPHCF stock price today per share is 17.2 USD.
How to purchase Rohto Pharmaceutical stock?
You can buy RPHCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rohto Pharmaceutical?
The stock symbol or ticker of Rohto Pharmaceutical is RPHCF.
Which industry does the Rohto Pharmaceutical company belong to?
The Rohto Pharmaceutical industry is Household & Personal Products.
How many shares does Rohto Pharmaceutical have in circulation?
The max supply of Rohto Pharmaceutical shares is 224.93M.
What is Rohto Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Rohto Pharmaceutical PE Ratio is 18.89659300 now.
What was Rohto Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Rohto Pharmaceutical EPS is 0.91 USD over the trailing 12 months.
Which sector does the Rohto Pharmaceutical company belong to?
The Rohto Pharmaceutical sector is Consumer Defensive.
